NCT01645176View on ClinicalTrials.gov

Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

October 31, 2016

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

Hydroxychloroquine/Atorvastatin

Hydroxychloroquine 200-600 mg /day Atorvastatin 40 mg/day

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01645176 - Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee | Biotech Hunter | Biotech Hunter